Search

everythinglearnresearchcommunity

for

Search:↓

Two gene areas linked to male pattern baldness found, more research needed.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

High BMI worsens hair growth in women with PCOS.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

AR polyglycine repeat doesn't cause baldness.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

A new gene, JMJD1C, may affect testosterone levels in men.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.